Polyomavirus replication & smoking are independent risk factors for bladder cancer after renal transplantation

Transplantation

Volumn 101, Issue 6, 2017, Pages 1488-1494

  Liu, Sandy ^a   Chaudhry, Muhammad R ^a   Berrebi, Alexander A ^a   Papadimitriou, John C ^a   Drachenberg, Cinthia B ^a   Haririan, Abdolreza ^a   Alexiev, Borislav A ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BK VIRUS; BLADDER CANCER; BLADDER CARCINOMA; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POLYOMAVIRUS; POLYOMAVIRUS INFECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SMOKING; URINE CYTOLOGY; VIREMIA; VIRUS REPLICATION; ADVERSE EFFECTS; GROWTH, DEVELOPMENT AND AGING; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; INCIDENCE; MARYLAND; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; POLYOMAVIRUS INFECTIONS; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; URINARY BLADDER NEOPLASMS; VIROLOGY;

IMMUNOSUPPRESSIVE AGENT;

ACADEMIC MEDICAL CENTERS; ADULT; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; MARYLAND; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; POLYOMAVIRUS; POLYOMAVIRUS INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; TIME FACTORS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; VIRUS REPLICATION;

EID: 84969916129     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000001260     Document Type: Article

References (43)

1. Billups K, Neal J, Salyer J. Immunosuppressant-driven de novo malignant neoplasms after solid-organ transplant. Prog Transplant. 2015;25:182-188.
2. Pierangeli A, Antonelli G, Gentile G. Immunodeficiency-associated viral oncogenesis. Clin Microbiol Infect. 2015;21:975-983.
3. Hevia V, Gómez V, Díez Nicolás V, et al. Development of urologic de novo malignancies after renal transplantation. Transplant Proc. 2014;46:170-175.
4. Medani S, O'Kelly P, O'Brien KM, et al. Bladder cancer in renal allograft recipients: risk factors and outcomes. Transplant Proc. 2014;46: 3466-3473.
5. Rossetto A, Tulissi P, De Marchi, F, et al. De novo solid tumors after kidney transplantation: is it time for a patient-tailored risk assessment? Experience from a single center. Transplant Proc. 2015;47:2116-2120.
6. Papadimitriou JC, Randhawa P, Rinaldo CH, et al. BK polyomavirus infection and renourinary tumorigenesis. Am J Transplant. 2016;16:398-406.
7. Drachenberg CB, Hirsch HH, Ramos E, et al. Polyomavirus disease in renal transplantation: review of pathological findings and diagnostic methods. Hum Pathol. 2005;36:1245-1255.
8. Hirsch HH, Randhawa P; AST Infectious Diseases Community of Practice. BK polyomavirus in solid organ transplantation. Am J Transplant. 2013; 13(Suppl 4):179-188.
9. Abend JR, Jiang M, Imperiale MJ. BK virus and human cancer: innocent until proven guilty. Semin Cancer Biol. 2009;19:252-260.
10. Burger M, Catto JW, Dalbagni G, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013;63:234-241.
11. Redondo-Gonzalez E, de Castro, LN, Moreno-Sierra J, et al. Bladder carcinoma data with clinical risk factors and molecular markers: a cluster analysis. Biomed Res Int. 2015;2015:168682.
12. Tsaur I, Karalis A, Probst M, et al. Development of urological cancers in renal transplant recipients: 30-year experience at the Frankfurt Transplant Center. Cancer Sci. 2010;101:2430-2435.
13. Vajdic CM, van Leeuwen, MT. Cancer incidence and risk factors after solid organ transplantation. Int J Cancer. 2009;125:1747-1754.
14. Muruve NA, Shoskes DA. Genitourinary malignancies in solid organ transplant recipients. Transplantation. 2005;80:709-716.
15. Ju MK, Joo DJ, Kim SJ, et al. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience. Transpl Int. 2009;22:644-653.
16. Li XB, Xing NZ, Wang Y, et al. Transitional cell carcinoma in renal transplant recipients: a single center experience. Int J Urol. 2008;15:53-57.
17. Alexiev BA, Drachenberg CB, Papadimitriou JC. Polyomavirus-cystitis associated with in situ and invasive urothelial carcinoma in a heart transplant recipient: evidence suggesting sequential progression/evolution from infection to carcinoma. Transplantation. 2015;99:e3-e4.
18. Alexiev BA, Papadimitriou JC, Chai TC, et al. Polyomavirus (BK)-associated pleomorphic giant cell carcinoma of the urinary bladder: a case report. Pathol Res Pract. 2013;209:255-259.
19. Alexiev BA, Randhawa P, Vazquez Martul, E, et al. BK virus-associated urinary bladder carcinoma in transplant recipients: report of 2 cases, review of the literature, and proposed pathogenetic model. Hum Pathol. 2013; 44:908-917.
20. Bialasiewicz S, Cho Y, Rockett R, et al. Association of micropapillary urothelial carcinoma of the bladder and BK viruria in kidney transplant recipients. Transpl Infect Dis. 2013;15:283-289.
21. Geetha D, Tong BC, Racusen L, et al. Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyomavirus as a causal transforming agent. Transplantation. 2002;73:1933-1936.
22. Hill P, Slavin J, Goodman D. High-grade urothelial carcinoma in a kidney transplant recipient with BK virus infection. NDT Plus. 2009;2:246-249.
23. Pino L, Rijo E, Nohales G, et al. Bladder transitional cell carcinoma and BK virus in a young kidney transplant recipient. Transpl Infect Dis. 2013;15:E25-E27.
24. Saquib R, Saad R, Savino DA, et al. Transitional cell carcinoma of renal allograft associated with BK virus infection. Dialysis Transplant. 2009; 38:518-519.
25. Grippo PJ, Sandgren EP. Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model. Am J Pathol. 2000;157:805-813.
26. Zhang ZT, Pak J, Shapiro E, et al. Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma. Cancer Res. 1999;59:3512-3517.
27. Shah BK, Mandal R. Survival trends in metastatic bladder cancer in the United States: a population based study. J Cancer Res Ther. 2015; 11:124-128.
28. Weinreb DB. BK virus and carcinoma of the prostate, kidney and bladder. Br J Cancer. 2006;94:1948; author reply 9-50.
29. Apel H, Walschburger-Zorn K, Haberle L, et al. De novo malignancies in renal transplant recipients: experience at a single center with 1882 transplant patients over 39 yr. Clin Transplant. 2013;27:E30-E36.
30. Hwang JK, Moon IS, Kim JI. Malignancies after kidney transplantation: a 40-year single-center experience in Korea. Transpl Int. 2011; 24:716-721.
31. VégsoG, Tóth M, HídvégiM, et al. Malignancies after renal transplantation during 33 years at a single center. Pathol Oncol Res. 2007;13:63-69.
32. Roberts IS, Besarani D, Mason P, et al. Polyoma virus infection and urothelial carcinoma of the bladder following renal transplantation. Br J Cancer. 2008;99:1383-1386.
33. Buzzeo BD, Heisey DM, Messing EM. Bladder cancer in renal transplant recipients. Urology. 1997;50:525-528.
34. Chen CH, Wen MC, Wang M, et al. High incidence of malignancy in polyomavirus-associated nephropathy in renal transplant recipients. Transplant Proc. 2010;42:817-818.
35. Chiang YJ, Yang PS, Wang HH, et al. Urothelial cancer after renal transplantation: an update. Transplant Proc. 2012;44:744-745.
36. Ehdaie B, Stukenborg GJ, Theodorescu D. Renal transplant recipients and patients with end stage renal disease present with more advanced bladder cancer. J Urol. 2009;182:1482-1487.
37. Kamal MM, Soliman SM, Shokeir AA, et al. Bladder carcinoma among live-donor renal transplant recipients: a single-centre experience and a review of the literature. BJU Int. 2008;101:30-35.
38. Yan L, Salama ME, Lanciault C, et al. Polyomavirus large T antigen is prevalent in urothelial carcinoma post-kidney transplant. Hum Pathol. 2016;48:122-131.
39. Moens U, Van Ghelue, M, Johannessen M. Oncogenic potentials of the human polyomavirus regulatory proteins. Cell Mol Life Sci. 2007;64: 1656-1678.
40. Coursaget P, Samimi M, Nicol JT, et al. Human Merkel cell polyomavirus: virological background and clinical implications. APMIS. 2013;121: 755-769.
41. Sharma SG, Nickeleit V, Herlitz LC, et al. BK polyoma virus nephropathy in the native kidney. Nephrol Dial Transplant. 2013;28:620-631.
42. Skinner GR. Transformation of primary hamster embryo fibroblasts by type 2 simplex virus: evidence for a "hit and run" mechanism. Br J Exp Pathol. 1976;57:361-376.
43. Griffiths TR. Action on bladder C. Current perspectives in bladder cancer management. Int J Clin Pract. 2013;67:435-448.